Grifols is a Spanish holding company specialized in the health-pharmaceutical sector and parent company of Grifols Group of companies. Probitas Pharma is active in the research, development, manufacture and marketing of plasma derivatives, I.V. therapy products (serums), enteral nutrition, reagents, instruments for clinical diagnostics and medical materials. All Probitas Pharma products and services are intended for promoting human health, and are used mainly in the hospital sector. Grifols prides itself on offering products of the highest quality, efficacy and safety.